January 30, 2013 | Search News | View as HTML 
Manage Resumes View Jobs Email Preferences
BioSpace GenePool. The Most Trusted Source for Daily Life Science News. Advertise in BioSpace GenePool
BioSpace GenePool
Like us on Facebook Follow us on Twitter Follow us on LinkedIn Subscribe via RSS Subscribe via Email
TOP SPONSOR

Pharm-Olam

Pharm-Olam has offices among the most populated cities in Europe, Latin America, India, South Africa, and the USA to provide cost effective coverage for oncology studies of all sizes. Pharm-Olam has helped bring 2 oncology compounds to NDA approval and have conducted oncology studies in over 30 countries. The majority of our clinical staff are MDs or PhDs, including oncologists in strategic areas for clinical trials. The incidence of oncology indications and standards of treatment can vary widely, so let Pharm-Olam conduct a complimentary feasibility study specific to your protocol and study budgets to use in your resource planning. Contact us at www.pharm-olam.com, info@pharm-olam.com, USA 1-713-559-7900, UK 44-0-1344-891121.

More Top Stories | Past Newsletters | News by Subject Refer GenePool to a ColleagueRefer GenePool to a Colleague
MIDDLE SPONSOR

Bio Research Supplies' Leading Seller of Low Price Pre-Owned Lab Consumables

We only deal in new unopened consumables which are subjected to our rigorous quality inspection before it is sold. Please click here for more information.

Position Employer Location
Scientist, Protein Engineering aTyr Pharma Inc. San Diego, CA
Senior QC Analyst Celgene Phoenix, AZ
Vice President of Product Development NovaBay Pharmaceuticals, Inc. Emeryville, CA
Sr. Statistician / Project Statistician Takeda Pharmaceuticals Chicago, IL
Associate Dir. / Dir., Health Outcomes & Payer Evidence Medimmune Gaithersburg, MD
More Jobs
Sign up for Job Alerts to find a job that's the perfect fit! Click here.
Biotech Firms Like Amgen (AMGN), Genzyme Corporation (GENZ) Race for Manufacturing Breakthrough More...
Beer's Bitter Compounds Could Help Brew New Medicines, University of Washington Study More...
ED May Signal Hidden Heart Disease, Australian National University Study More...
Cancer Gene Mutation Linked to Earlier Menopause, University of California, San Francisco (UCSF) Study More...
Popular AntidepressantsTied to Irregular Heartbeat, Massachusetts General Hospital Study More...
Wake Forest University Baptist Medical Center Study Shows How Stress Feeds Cancer Cells More...
Link Found Between Insulin Sensitivity, Cells' Powerhouses, University of Texas Health Science Center Study More...
Husbands Who Do More Housework Have Less Sex, Juan March Institute and University of Washington Study More...
More News | Past Newsletters | News by Subject Refer GenePool to a ColleagueRefer GenePool to a Colleague
Resources

Resources

Company Profiles
Cover Letters
Resume Advice
Interviews
Salary
Hotbeds

Hotbeds

Genetown
Bio NC
BioCapital
Pharm Country
BioMidwest
Career Fairs

Career Fairs

2/21 Genetown
3/07 BioNC
3/14 Pharm Country
3/21 Biotech Bay
          Register Now!

SafeBridge Consultants, Inc. announces two Potent Compound Safety Training offerings (may be taken separately or consecutively)

The SafeBridge original Potent Compound Safety "Boot Camp"® (Boot Camp I) is a comprehensive two-day course in pharmaceutical potent compound safety focused on training EH&S and related professionals in critical technical concepts and proactive safety programs in pharmaceutical industrial hygiene, occupational and environmental toxicology, analytical chemistry, and risk communication.
The SafeBridge Advanced Concepts to Support Drug Development of Potent Compounds from R&D through Manufacturing (Boot Camp II) is a one-day advanced course focused on case studies and problem-solving to address potent compound safety issues in discovery, development, contract manufacturing and commercialization.
COURSE SEATING IS LIMITED AND USUALLY SELLS OUT!
San Francisco (USA)
Boot Camp I March 5-6, 2013
Boot Camp II March 7, 2013
Contact: Susan Custer: susan.custer@safebridge.com or 650-961-4820 x 231 or www.safebridge.com.


BioSpace.com Releases 2013 Life Sciences / Biotech Employment Outlook

To learn more about the current state of life sciences / biotechnology careers, download the full BioSpace Annual Report: Life Sciences Employment Outlook.

 

More Events

Post Your:   News   |   Jobs   |   Company Profile   |   Event   |   Advertising/Sponsorship

This email was sent by BioSpace.com. Please distribute this e-cast freely. Subscribe to our newsletter. To unsubscribe or update your email preferences, click here. This request may take up to 10 business days to take effect.

BioSpace.com is an onTargetjobs, Inc. company and respects your time and privacy. BioSpace.com is not responsible for offers, products, services, or other information expressed or made available by third parties and provided by any off-site Internet page referenced through this email's hypertext. While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. To guarantee receipt of BioSpace.com emails, add newsletters@email.biospace.com to your address book.

Contact the News Team Email: news@biospace.com; Toll Free: (877) 277-7585; 6465 S. Greenwood Plaza Blvd., Ste. 400, Centennial, CO 80111
Send questions and comments to the BioSpace News Beat Team.
Editor & Publisher: Lana Ho
Editorial & Production Staff: Maysa Darwish, Tammy Liu

© 2013 onTargetjobs, Inc. All rights reserved. BioSpace.com is a registered trademark of onTargetjobs, Inc. All other trademarks and registered trademarks are the property of their respective owners.